Access your Pro+ Content below.
Antimalware product suites: Understanding capabilities and limitations
This article is part of the October 2011 issue of Information Security magazine
Protecting endpoint computers from malware is critical to providing reliable operations, safeguarding data and maintaining an acceptable compliance posture. Standalone antivirus products of the past have matured to encompass a variety of tools for securing endpoints in an enterprise setting. As the threats associated with malicious software increase in sophistication, so do the capabilities of antimalware tools. Understanding the capabilities and limitations of components that form an enterprise antimalware suite is critical to selecting the right product for your organization and deriving value from it. One way to understand what components we can expect to find in an antimalware product suite is to consider how malicious software often propagates: Through the victim’s browser Via email in the form of malicious links and attachments Through local network and removable media Via exploits and social engineering tricks An antimalware product suite should tackle all these infection vectors, attempting to stop malware before it ...
Access this PRO+ Content for Free!
By submitting your email address, you agree to receive emails regarding relevant topic offers from TechTarget and its partners. You can withdraw your consent at any time. Contact TechTarget at 275 Grove Street, Newton, MA.
Features in this issue
Hear from the winners of this year's Information Security magazine Security 7 Award.
Traditional antivirus tools have matured into multi-featured antimalware suites. Here’s what you should know when shopping for endpoint protection.
The breaches of certificate authorities fuel renewed debate for Internet security alternatives.
Columns in this issue
This year’s Security 7 Award winners represent a bright spot in an industry beset by bad news.
An InfoSec Leaders survey examines the impact of different certs on the security profession.
Networked medical devices introduce new risks but does a new standard go far enough in addressing the problem?